Adaptimmune Therapeutics plc (ADAP) Tumbled -5.04% or -0.58 To Price $10.94 On Tuesday


Adaptimmune Therapeutics plc (ADAP) tumbled -5.04% or -0.58 to $10.94. It is about 487277 shares traded, which is 113.38% compare to the average total volume 429770. The market cap of ADAP is $1.03 billion. The year to date change is 57.22%. The 52 week price range is from $6.35 to $14.62. Price of ADAP have changed 10.03% during last week. It have changed 22.16% over last month, -13.06% over last 3 months, 50.98% over last 6 months and 91.68% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 10.34. It is -5.48% below current price. The 200-day Moving Averages for ADAP is 10.03. It is -8.32% below current price. The 52-week High is 14.62. It is 33.64% from the current price. The 52-week Low is 6.35. It is -41.96% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ADAP is 5.67 on 2018-08-15. Short % to float is 3.98%. There are some statistics of ADAP. It is has market cap $1.03 billion. The share outstanding is 94.42 million. The average volume is 429770. The revenue is 27.19M. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -47.00%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -37.42%.


Tags:

Share this post